TOP NEWS: AstraZeneca buys France’s Amolyt Pharma for $1 billion
AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.
The Cambridge-based pharmaceutical company...
Thu, 14/03/2024 - 10:01